The Dichloromethane Fraction of Sanguisorba tenuifolia Inhibits Inflammation in Cells Through Modulation of the p38/ERK/MAPK and NF-κB Signaling Pathway
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26146732 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yue Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Agronomy, Yanbian University, Yanji 133002, China. Hauptthemen laut MEDLINE: NF-kappa B, Plant Extracts, Anti-Inflammatory Agents, Sanguisorba. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Project of Provincial Department of Education, Yanbian University Doctoral Initiation Fund, Science and Technology Project of the Provincial Department of Education.
Abstract (Originalsprache)
Sanguisorba tenuifolia is a wild plant of the genus Sanguisorba officinalis. This study aimed to investigate the regulatory effect of the dichloromethane fraction of Sanguisorba tenuifolia on LPS-induced inflammatory responses in RAW264.7 cells, thereby providing a new scientific basis for the medicinal development of Sanguisorba tenuifolia. Initially, we used 75% ethanol to crudely extract the roots of Sanguisorba tenuifolia, followed by fractional extraction using dichloromethane (CH2Cl2), ethyl acetate (EtOAc), butanol (BuOH), and distilled water (DW) as solvents. By measuring the inhibitory effects of each fractionated extract on NO production, we determined that the SCE (Dichloromethane fraction of Sanguisorba tenuifolia) exhibited the most potent anti-inflammatory activity, leading to its progression to the next experimental stage. Subsequently, we evaluated the effects of SCE on cell viability and LPS-induced inflammatory cytokine secretion in RAW264.7 cells. A rat model of reflux esophagitis was also used to validate the in vivo anti-inflammatory effects of SCE. Additionally, we utilized UPLC/MS-MS to identify and analyze the active components of SCE. The results indicated that SCE could effectively inhibit LPS-induced cellular inflammation by modulating the p38/ERK/MAPK and NF-κB signaling pathways, and also reduced the damage of the esophageal mucosa in rats with reflux esophagitis. UPLC/MS-MS analysis of SCE identified 423 compounds, including 12 active ingredients such as triterpenoids, phenols, and steroids. This discovery not only provides scientific support for the potential of Sanguisorba tenuifolia as an anti-inflammatory agent but also lays the groundwork for the development of new therapeutics for the treatment of inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Agronomy, Yanbian University, Yanji 133002, China.
- Department of Crop Life Sciences, College of Agricultural Life Sciences, Jeonbuk National University, 567 Baekje-daero, Deokjin-gu, Jeonju-si 54896, Jeonbuk State, Republic of Korea.
ORCID-Profile: Hyeon Hwa Nam
Förderung
- Science and Technology Project of Provincial Department of Education
- Yanbian University Doctoral Initiation Fund
- Science and Technology Project of the Provincial Department of Education
Zitieren
APA
Wang, Y., Lu, Y., Niu, F., Fa, S., Nan, L., & Nam, H. H. (2025). The Dichloromethane Fraction of Sanguisorba tenuifolia Inhibits Inflammation in Cells Through Modulation of the p38/ERK/MAPK and NF-κB Signaling Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26146732
Vancouver
Wang Y, Lu Y, Niu F, Fa S, Nan L, Nam HH. The Dichloromethane Fraction of Sanguisorba tenuifolia Inhibits Inflammation in Cells Through Modulation of the p38/ERK/MAPK and NF-κB Signaling Pathway. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26146732
BibTeX
@article{Wang2025,
author = {Wang, Yue and Lu, Yiming and Niu, Fuao and Fa, Siqi and Nan, Li and Nam, Hyeon Hwa},
title = {The Dichloromethane Fraction of Sanguisorba tenuifolia Inhibits Inflammation in Cells Through Modulation of the p38/ERK/MAPK and NF-κB Signaling Pathway},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26146732}
}
EUVIMED